L. Rubin

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial

G. Simonneau, E. Chiossi, N. Galiè, 2008, The Lancet.

A decade of achievement in pulmonary hypertension

M. Humbert, G. Simonneau, L. Rubin, 2011, European Respiratory Review.

Erratum: "Survival with first-line bosentan in patients with primary pulmonary hypertension" (European Respiratory Journal (2005) vol. 25 (244-249))

R. Barst, D. Badesch, G. Simonneau, 2005 .

Anaesthetic depth and complications after major surgery: an international, randomised controlled trial

K. Leslie, M. Edwards, J. Dieleman, 2019, The Lancet.

End-points and clinical trial design in pulmonary arterial hypertension: have we made progress?

A. Peacock, R. Naeije, A. Peacock, 2009, European Respiratory Journal.

Risk assessment in pulmonary arterial hypertension (PAH): Insights from the GRIPHON study

H. Ghofrani, R. Benza, G. Simonneau, 2018, Pneumologie.

P149 Effect of macitentan on pulmonary arterial hypertension-related hospitalisations: results from the randomised controlled SERAPHIN trial

L. Perchenet, L. Rubin, R. Channick, 2013, Thorax.